Aceso Life Science Group Limited (HKG:0474)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1500
+0.0040 (2.74%)
Aug 21, 2026, 4:08 PM HKT

Aceso Life Science Group Financials Overview

Millions HKD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
-68-68-7111207170
Revenue Growth
----94.69%21.77%-
Operating Income
-150-150-290-224-90-136
Net Income
338338-895-462-264-370
Earnings Per Share
0.050.05-0.12-0.06-0.04-0.06
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Property Leasing
-68-6825293145
Rental and Sale of Construction Machinery and Spare Parts
--133153227165
Provision of Repair and Maintenance and Transportation Service
--66810
Money Lending
---56-853046
Provision of Asset Management, Securities Brokerage and Other Financial Services
--1071414
Unallocated Finance Costs
---96-111-101-126
Unallocated Reversal of Impairment Losses of Financial Assets (Expected Credit Losses)
---9414911
Total
-68-68-7213218165

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
326326212469602717
Total Debt
1,2081,2082,3012,7382,9223,010
Net Cash (Debt)
-882-882-2,089-2,269-2,320-2,293
Net Cash Growth
------
Net Cash Per Share
-0.12-0.12-0.29-0.31-0.32-0.31

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--17-37214316
Capital Expenditures
---2-11-24-57
Free Cash Flow
--15-48190259
Free Cash Flow Growth
-----26.64%57.93%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Margin
----2036.36%-43.48%-80.00%
Pretax Margin
619.12%619.12%1446.48%-7481.82%-102.90%-326.47%
Profit Margin
----4200.00%-127.54%-217.65%
FCF Margin
----436.36%91.79%152.35%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
3.933.12----
P/FCF Ratio
--24.61-6.921.82
PS Ratio
-19.54-15.50-5.20106.706.352.78